njletop.com

About Us

About Us

We are committed to ensuring that every product we produce has verifiable functional characteristics and meets controllable quality standards, using science to advance global health and beauty.

Company Profile

Nanjing Letop Biotechnology Co., Ltd. is a high-tech enterprise specializing in the R&D, manufacturing, and commercialization of functional ingredients. Built on our fermentation platform and core enzymatic catalysis technologies, we combine pharmaceutical-grade standards with end-to-end quality management to develop high-purity, high-activity functional ingredients supported by scientific validation.

Today, we provide more than 20 functional ingredients for commercial supply, serving a broad range of applications across nutraceuticals, food, medical aesthetics, cosmetics, and pharmaceutical intermediates.

Nutraceuticals & Food Ingredients

Our nutraceuticals and food ingredient portfolio includes LetopCS® Chondroitin Sulfate Oligosaccharide, LetopEP® Earthworm Protein, LetopEP® Earthworm Protein Peptides, Gamalax® GABA, Ostryon® Cartilage Protein Powder, Salmon Protamine Peptides(Food-grade PDRN), Sodium Hyaluronate,NMN Enteric-Coated Granules, and more.

These ingredients are intended for use in general foods, health foods, and cross-border dietary supplements. Customers are responsible for ensuring that product labeling, intended use, and marketing claims comply with the applicable laws, regulations, and requirements governing the final product category and market.

 

Medical Aesthetics & Cosmetic Ingredients

Our medical aesthetics and cosmetic ingredient portfolio includes PDRN (Polydeoxyribonucleotide), PN (Polynucleotides), nmHA® Ultra-Low Molecular Weight Sodium Hyaluronate, customized molecular weight Sodium Hyaluronate series, Acetylated Sodium Hyaluronate, Cationic Sodium Hyaluronate, Low-Endotoxin Sodium Hyaluronate, Ectoin, Ergothioneine, GABA,LetopCS® Chondroitin Sulfate Sodium, and more.

These ingredients are developed for applications across medical aesthetics and cosmetic formulations, with product specifications and grades available according to specific application requirements.

Pharmaceutical Intermediates

Our pharmaceutical intermediate portfolio includes Insulin Degludec Side Chain, Semaglutide Side Chain, Chloroacetyl Catechol, Medroxyprogesterone, Epinephrine, Recombinant CPB Enzyme, Recombinant Kex II Enzyme, and more.

These products are supplied as pharmaceutical intermediates and related specialized materials for use in downstream pharmaceutical manufacturing and process development, subject to applicable regulatory requirements and customer-specific applications.

To become the most trusted platform for professional solutions in the global functional ingredients sector.

Applying pharmaceutical-grade standards to create safe and effective raw materials for the functional nutrition, beauty, and pharmaceutical industries

Our Values

Science-Based

Every benefit is backed by data, and every safety measure is verified.

Quality First

We adhere to a pharmaceutical-grade quality system and strictly control every step of the process.

Cross-Disciplinary Thinking

Understanding the principles of nutrition, skincare, and pharmaceuticals simultaneously, and breaking down industry barriers

Platform Empowerment

From raw materials to finished products, we provide customers with one-stop support

Global Trust

Earning the long-term trust of global markets through results and integrity

History

  • 2013

• Nanjing Letop Biotechnology Co., Ltd. was established.

2013
2017
  • 2017

• Initiated a biotechnology project for the research of ultra-low molecular weight sodium hyaluronate (nmHA®)
• Added a production line for cosmetic raw materials

  • 2020

• Added a production line for GABA (gamma-aminobutyric acid)

2020
2020
  • 2020

• Added multiple production lines to achieve large-scale production of hyaluronic acid with varying molecular weights and LetopCS® products.
• Obtained production licenses for pressed candy and the food additive GABA.
• Successfully entered the Japanese market.

  • 2021

• Obtained production licenses for compressed candy and GABA
• Achieved multiple quality management certifications, including ISO9001, ISO22716, GMPC, and EFfCI
• Successfully achieved mass production of multi-molecular-weight hyaluronic acid and LetopCS® (low-molecular-weight chondroitin)

2021
2022
  • 2022

• Operated independently, with business operations expanding into sectors such as food, cosmetics, and active pharmaceutical ingredients (APIs)
• Signed a joint laboratory R&D cooperation agreement with Jiangnan University
• Established a joint postgraduate workstation with Nanjing Tech University

  • 2023

• Signed Academician Chen Jian as Chairman of the Technical Committee
• Awarded "High-Tech Enterprise" certification and completed Intellectual Property Management System certification
• LetopCS® obtained US GRAS certification
• Granted Jiangsu’s first food production license for earthworm protein and a production license for GABA-based foods
• Acquired the US brand company Naturastar and established a cross-border business platform; launched construction of the API production base, accelerating the implementation of the industrial layout

2023
2024
  • 2024

• Obtained production license for solid beverages; became a council member of the School of Biotechnology at Jiangnan University; successfully completed US FDA facility registration, South Korean manufacturer registration, and Medical Device Master File (MDMF) filing.
• Accelerated construction of the Mingyang and Lianyungang production bases; expanded US-based Naturastar’s e-commerce operations across multiple platforms.
• Launched multiple nutritional and health supplement brands, including Huoliying and Jianweili.

  • 2025

• Obtained production licenses for GABA flavoring, earthworm protein peptides, and salmon protamine peptides; secured ISO9001 quality management system certification, solidifying the foundation for quality.
• Successfully registered 37 trademarks.
• Raw materials won five industry awards, boosting brand momentum.
• Completed Phase I infrastructure at the Lianyungang Minghai facility, expanding production capacity.
• Established the first labor union at Letop Biotech, upgrading organizational standardization.
• Established a Party branch, elevating Party-building efforts to a new level; launched the COCOPHIL pet health supplement brand.

2025

Honors and Certifications

Corporate Social Responsibility

At Nanjing Letop Biotechnology, we are committed to advancing sustainable development through scientific and technological innovation. We integrate environmental and social responsibility into every aspect of our development and strive to create long-term value through responsible action.

Business Partnerships

Nanjing Letop Biotechnology Co., Ltd.

Exit mobile version